Subclinical carotid atherosclerosis in patients with chronic obstructive pulmonary disease: a meta-analysis of literature studies

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD): global strategy for the diagnosis, management and prevention of COPD; 2009. Available from: http://www.goldcopd.org
   Google Scholar
• Hurd SS, Lenfant C. COPD: good lung health is the key. Lancet. 2005;366:1832–1834.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504.
   PubMed Web of Science ®Google Scholar
• Evans RA, Morgan MD. The systemic nature of chronic lung disease. Clin Chest Med. 2014;35:283–293.
   PubMed Web of Science ®Google Scholar
• Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109.
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952e9.
   Web of Science ®Google Scholar
• Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2:8–11.
   PubMedGoogle Scholar
• Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest. 2007;131:1557–1566.
   PubMed Web of Science ®Google Scholar
• Cebron Lipovec N, Beijers RJ, van den Borst B, et al. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD. 2016;13:399–406.
   PubMedGoogle Scholar
• Stone IS, Barnes NC, Petersen SE. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart. 2012; 98:1055–1062.
   PubMed Web of Science ®Google Scholar
• Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension. 2006;48:392–396.
   PubMed Web of Science ®Google Scholar
• Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther. 2002;16:341–351.
   PubMed Web of Science ®Google Scholar
• de Groot E, Hovingh GK, Wiegman A, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004;109:III33–III38.
   PubMed Web of Science ®Google Scholar
• O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22.
   PubMed Web of Science ®Google Scholar
• Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol. 1997;146:483–494.
   PubMed Web of Science ®Google Scholar
• Belcaro G, Nicolaides AN, Ramaswami G, et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study). Atherosclerosis. 2011;156:379–387.
   Web of Science ®Google Scholar
• Albu A, Fodor D, Bondor C, et al. Carotid arterial stiffness in patients with chronic obstructive pulmonary disease. Acta Physiol Hung. 2011;98:117–127.
   PubMedGoogle Scholar
• Arsovski Z, Gavrilovski M, Kaeva B, et al. Carotid wall intima-media thickness (IMT) in COPD patients. Eur Res J. 2013;42:3667.
   Web of Science ®Google Scholar
• Joshi RW, Agrawal R, Pandharipande MS, et al. Carotid intima media thickness in chronic obstructive pulmonary disease. VJIM. 2016;20:19–23.
   Google Scholar
• Sadek SH, Hassan AA, AbdElrahman G, et al. Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation. Egypt J Bronchol. 2015;9:140–145.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. Ottawa Hospital Research Institute. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32:829–849.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101–105.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463.
   PubMed Web of Science ®Google Scholar
• Beşir FH, Yılmaz Aydın L, Yazgan Ö, et al. Evaluation of carotid intima media thickness in chronic obstructive pulmonary disease patients. Tuberk Toraks. 2012;60:238–245.
   PubMedGoogle Scholar
• Chindhi S, Thakur S, Sarkar M, et al. Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: prospective hospital-based case control study. Lung India. 2015;32:137–141.
   PubMed Web of Science ®Google Scholar
• Ekin S, Arısoy A, Gunbatar H, et al. The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD. Redox Rep. 2016;15:1–4.
   Google Scholar
• Fisk M, Mäki Petäjä K, Gale N, et al. Carotid intima-media thickness and aortic stiffness are elevated in chronic obstructive pulmonary disease (COPD) subjects compared to controls and not associated with systemic inflammation. Circulation. 2015;132:A12457.
   Google Scholar
• Flu WJ, van Kuijk JP, Hoeks SE, et al. Intima media thickness of the common carotid artery in vascular surgery patients: a predictor of postoperative cardiovascular events. Am Heart J. 2009;158:202–208.
   PubMed Web of Science ®Google Scholar
• Frantz S, Nihlén U, Dencker M, et al. Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods. Clin Physiol Funct Imaging. 2012;32:120–125.
   PubMed Web of Science ®Google Scholar
• Golpe R, Mateos-Colino A, Testa-Fernández A, et al. Blood pressure profile and hypertensive organ damage in COPD patients and matched controls. The RETAPOC study. PLoS ONE. 2016;11:e0157932.
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med. 2009;179:35–40.
   PubMed Web of Science ®Google Scholar
• Karakas O, Cullu N, Karakas E, et al. Evaluation of carotid intima-media thickness in the patients with chronic obstructive pulmonary disease. Acta Med Mediterran. 2013;29:265–267.
   Web of Science ®Google Scholar
• Kim SJ, Yoon DW, Lee EJ, et al. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2011;15:1265–1270.
   PubMed Web of Science ®Google Scholar
• Köseoğlu C, Kurmuş Ö, Ertem AG, et al. Association between carotid intima-media thickness and presence of coronary artery disease in chronic obstructive pulmonary disease patients. Anatol J Cardiol. 2016;16:601–607.
   PubMed Web of Science ®Google Scholar
• Lahousse L, van den Bouwhuijsen QJ, Loth DW, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med. 2013;187:58–64.
   PubMed Web of Science ®Google Scholar
• Ozgen Alpaydin A, Konyar Arslan I, Serter S, et al. Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease. Multidiscip Respir Med. 2013;8:61.
   PubMed Web of Science ®Google Scholar
• Pan J, Xu L, Cai SX, et al. The association of pulmonary function with carotid atherosclerosis in older Chinese: Guangzhou Biobank Cohort Study-CVD Subcohort. Atherosclerosis. 2015;243:469–476.
   PubMed Web of Science ®Google Scholar
• van Gestel YR, Flu WJ, van Kuijk JP, et al. Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med. 2010;104:712–716.
   PubMed Web of Science ®Google Scholar
• Moro L, Pedone C, Scarlata S, et al. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology. 2008;59:357–364.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514–1519.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Lupoli R, Spadarella G, et al. Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies. J Gastrointestin Liver Dis. 2015;24:25–34.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Lupoli R, Tarantino P, et al. Viral hepatitis and anti-phospholipid antibodies positivity: a systematic review and meta-analysis. Dig Liver Dis. 2015;47:478–487.
   PubMedGoogle Scholar
• Ambrosino P, Tasso M, Lupoli R, et al. Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies. Ann Med. 2015;47:457–467.
   PubMed Web of Science ®Google Scholar
• van der Meer IM, Bots ML, Hofman A, et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109:1089–1094.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Tarantino L, Di Minno G, et al. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost. 2017;117:139–148.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol. 2007;85:141–147.
   PubMed Web of Science ®Google Scholar
• Quaglia LA, Freitas W, Soares AA, et al. C-reactive protein is independently associated with coronary atherosclerosis burden among octogenarians. Aging Clin Exp Res. 2014;26:19–23.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843.
   PubMed Web of Science ®Google Scholar
• Man SF, Connett JE, Anthonisen NR, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax. 2006;61:849–853.
   PubMed Web of Science ®Google Scholar
• Schols AM, Creutzberg EC, Buurman WA, et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1220–1226.
   PubMed Web of Science ®Google Scholar
• Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1179–1184.
   PubMed Web of Science ®Google Scholar
• Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1414–1418.
   PubMed Web of Science ®Google Scholar